1. Home
  2. CCK vs ALGN Comparison

CCK vs ALGN Comparison

Compare CCK & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$98.43

Market Cap

11.2B

Sector

Industrials

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.47

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCK
ALGN
Founded
1906
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
10.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CCK
ALGN
Price
$98.43
$157.47
Analyst Decision
Strong Buy
Buy
Analyst Count
14
13
Target Price
$118.57
$190.50
AVG Volume (30 Days)
2.1M
1.6M
Earning Date
10-20-2025
10-29-2025
Dividend Yield
1.06%
N/A
EPS Growth
888.69
N/A
EPS
8.10
5.16
Revenue
$12,141,000,000.00
$3,982,622,000.00
Revenue This Year
$4.78
$2.58
Revenue Next Year
$2.75
$3.41
P/E Ratio
$12.09
$30.45
Revenue Growth
3.27
0.56
52 Week Low
$75.98
$122.00
52 Week High
$109.48
$246.19

Technical Indicators

Market Signals
Indicator
CCK
ALGN
Relative Strength Index (RSI) 52.92 73.38
Support Level $96.66 $144.00
Resistance Level $100.12 $152.99
Average True Range (ATR) 1.88 4.97
MACD 0.16 1.74
Stochastic Oscillator 67.91 92.40

Price Performance

Historical Comparison
CCK
ALGN

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: